BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11859306)

  • 21. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
    Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
    Harrison C; Young J; Navi D; Riaz N; Lingala B; Kim Y; Hoppe R
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e651-7. PubMed ID: 21489711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of mycosis fungoides management by total skin electron beam therapy with "translational technique".
    Gamsiz H; Beyzadeoglu M; Sager O; Dincoglan F; Uysal B; Demiral S; Gundem E; Dirican B
    J BUON; 2015; 20(4):1124-31. PubMed ID: 26416066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
    Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
    Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Whole-skin electron therapy: a therapeutic concept for mycosis fungoides and Sézary syndrome. 2: Therapy].
    Herbst M
    Strahlentherapie; 1984 Mar; 160(3):154-8. PubMed ID: 6729855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly total skin electron beam therapy for mycosis fungoides and other cutaneous lymphomata: further experience.
    D'Angio GJ; Nisce LZ; Kim JH
    Br J Cancer Suppl; 1975 Mar; 2():379-85. PubMed ID: 810154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Total cutaneous electron beam therapy of mycosis fungoides].
    Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
    Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
    Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
    Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
    Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
    Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
    J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycosis fungoides and radiotherapy. Value of the combination: total skin electron therapy and whole-body photon therapy].
    Lambert D; Bousser AM; Dalac S; Godard W; Lepinoy D; Horiot JC
    Ann Dermatol Venereol; 1986; 113(6-7):541-7. PubMed ID: 3545028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.
    Piccinno R; Caccialanza M; Percivalle S
    J Dermatolog Treat; 2009; 20(3):165-8. PubMed ID: 18979277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
    Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
    Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
    Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    Introcaso CE; Micaily B; Richardson SK; Junkins-Hopkins JM; Yoon JS; Kim EJ; Vittorio CC; Rook AH
    J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
    Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
    Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome).
    Jones GW; Rosenthal D; Wilson LD
    Cancer; 1999 May; 85(9):1985-95. PubMed ID: 10223240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.